Trial Profile
68Ga-PSMA PET/CT vs. MRI/CT vs. lymphadenectomy for the identification of lymph node metastases in locally advanced prostate cancer patients: a diagnostic test accuracy study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2017
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Diagnostic-imaging-abnormalities
- Focus Diagnostic use
- 03 Mar 2017 Status changed from recruiting to completed.
- 07 Feb 2015 New trial record